Valvular and Hypertensive Heart Disease
Valvular and Hypertensive Heart Disease

Valvular and Hypertensive Heart Disease

by Richard Mitchell, MD

Valvular heart disease (VHD) refers to valvular dysfunction in the heart secondary to a number of possible etiologies, including degenerative disease, autoimmune and infectious causes, and even malignancy. Generally, VHD is a surgical problem, but early identification of the disease requires a thorough history and physical examination, especially via auscultation and the assessment of JVD and volume status. This assessment is complemented by imaging and laboratory evaluation, which can accurately quantify the extent of dysfunction and determine the best approach for therapeutic interventions, if necessary.

Hypertensive heart disease is a sort of catch-all term referring to the cardiac sequelae of chronically elevated blood pressure, causing dystrophic remodeling of the left ventricle, dilation and remodeling of the left atrium, and degenerative changes to the coronary arteries. Patients with hypertensive heart disease suffer from significantly increased morbidity and mortality.

Course Details

  • Videos 14
  • Duration 1:23 h
  • Quiz questions 56
  • Concept Pages 12

Content

Your Educators of course Valvular and Hypertensive Heart Disease

 Richard Mitchell, MD

Richard Mitchell, MD

Dr. Richard N. Mitchell is the Lawrence J. Henderson Professor of Pathology and Health Sciences and Technology, at Harvard Medical School in Massachusetts, USA.

He obtained his PhD in Cell Biology and Immunology from Rockefeller University in 1980, and his MD from Harvard Medical School in 1984. Currently, he is Program Director of the Health Sciences and Technology Education and Curriculum at Harvard Medical School.

Due to his achievements, he earned the ASIP Robbins Distinguished Educator Award in 2013.

Within Lecturio, Dr. Mitchell teaches courses on Pathology.


User reviews

(1)
5,0 of 5 stars
5 Stars
1
4 Stars
0
3 Stars
0
2 Stars
0
1  Star
0
 
asdasdasfgasf
By rouzbeh t. on 06. August 2022 for Regurgitation and Clinical Consequences โ€“ Valvular Heart Disease

fwqfqwf wqgqwg qwa fwqfqwf wqgqwg qwa fwqfqwf wqgqwg qwa fwqfqwf wqgqwg qwa fwqfqwf wqgqwg qwa